Company / Capital Returned to Shareholders per Share
Corcept Therapeutics Incorporated Capital Returned to Shareholders per Share History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Returned to Shareholders per Share
$1.65
FY2025
5-year range
$0.00 / $1.65
FY2021-FY2025
Trend
+986.0%
vs FY2024
Sector context
#19 of 51
Health Care
What the data says
Capital Returned to Shareholders per Share changed +986% YoY in FY2025, a notable deviation from the 2-year average annual change of +443%.
Based on SEC 10-K filings.
1.65 in FY2025 with a 5-year CAGR of +51.4%.
Improved from $0.00 to $1.65 over the past 2 years.
Health Care sector context is included.
Capital Returned to Shareholders per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- +51.4%
- 10-Year CAGR
- -
Sector benchmark
#19 of 51 in Health CareTop 37% of 51This company $1.65 Sector average $2.74
▼
-39.9% below sector average
Key checks
Key Insights
- In FY2025, capital returned to shareholders per share increased 986.0% year-over-year.
- Ranks #19 out of 51 companies in the Health Care sector.
- Lowest capital returned to shareholders per share in the period was in FY2023.
Company context
Key Data Points
- Altman Z-Score 3.44 (safe zone, above 2.9 threshold)
- Strong profit margin: 20.9%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital Returned to Shareholders per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.65 | +986.0% |
| FY2024 | $0.15 | - |
| FY2023 | $0.00 | - |
| FY2022 | - | - |
| FY2021 | - | - |
| FY2020 | $0.21 | - |
| FY2019 | $0.00 | - |
| FY2018 | $0.00 | - |
| FY2017 | $0.00 | - |
| FY2016 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026